As part of ongoing efforts to enhance and advance treatment methods through the adoption of the latest technologies, Brigadier General Dr. Shaikh Fahad bin Khalifa bin Salman Al Khalifa, Commander of the Royal Medical Services (RMS), announced the adoption of “Sentiva” technology as an effective and innovative tool for the treatment of epilepsy. The technology, a first of its kind, is now being utilised in Bahrain and the Gulf region.
A medical team from the Royal Medical Services at the Military Hospital, comprising Dr. Mohammed Al Mahraqi, Consultant in Oral, Maxillofacial, and Neck Surgery, Dr. Mohammed Al Shihabi, Consultant in Ear, Nose, and Throat Surgery, and Dr. Raafat Hammad Sarour, Consultant in Paediatric Neurology, successfully treated two advanced epilepsy cases using Sentiva technology.
The team conducted comprehensive evaluations and diagnoses of the patients, both of whom were diagnosed with advanced epilepsy that did not respond to medication. After thorough assessments and considering international protocols and the individual characteristics of the disease, the team developed a tailored treatment plan.
The treatment involved performing surgical procedures to implant electrodes using the “Sentiva” device, followed by placing the neurostimulator under the skin, typically in the chest area. Post-surgery, the neurostimulation device was programmed and adjusted to meet the specific needs of each patient.
The procedure took approximately one hour and was successfully completed, enabling the patients to resume their normal lives without experiencing recurrent seizures.
“Sentiva” is among the most advanced medical technologies, using a sophisticated mechanism to stimulate the vagus nerve to reduce seizure frequency, particularly in patients unresponsive to conventional treatments. The device allows physicians to adjust stimulation levels to suit individual patient needs, ensuring long-term therapeutic benefits.
BNA(R)
